SI1349549T1 - Novi sestavki zdravila na osnovi tiotropijevih soli in ciklezonida - Google Patents
Novi sestavki zdravila na osnovi tiotropijevih soli in ciklezonidaInfo
- Publication number
- SI1349549T1 SI1349549T1 SI200130953T SI200130953T SI1349549T1 SI 1349549 T1 SI1349549 T1 SI 1349549T1 SI 200130953 T SI200130953 T SI 200130953T SI 200130953 T SI200130953 T SI 200130953T SI 1349549 T1 SI1349549 T1 SI 1349549T1
- Authority
- SI
- Slovenia
- Prior art keywords
- ciclesonide
- tiotropium
- salts
- compositions based
- medicament compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10062712A DE10062712A1 (de) | 2000-12-15 | 2000-12-15 | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
PCT/EP2001/014579 WO2002047668A2 (de) | 2000-12-15 | 2001-12-12 | Neue arzneimittelkompositionen auf der basis von anticholinergika und ciclesonide |
EP01991827A EP1349549B1 (de) | 2000-12-15 | 2001-12-12 | Neue arzneimittelkompositionen auf der basis von tiotropiumsalzen und ciclesonide |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1349549T1 true SI1349549T1 (sl) | 2010-01-29 |
Family
ID=7667386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200130953T SI1349549T1 (sl) | 2000-12-15 | 2001-12-12 | Novi sestavki zdravila na osnovi tiotropijevih soli in ciklezonida |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040266869A1 (sl) |
EP (2) | EP2105143B8 (sl) |
JP (1) | JP4537652B2 (sl) |
AT (1) | ATE444067T1 (sl) |
AU (2) | AU2002231691A1 (sl) |
CA (1) | CA2431565C (sl) |
CY (2) | CY1110582T1 (sl) |
DE (2) | DE10062712A1 (sl) |
DK (2) | DK1349549T3 (sl) |
ES (2) | ES2334104T3 (sl) |
MX (1) | MXPA03005340A (sl) |
PT (2) | PT1349549E (sl) |
SI (1) | SI1349549T1 (sl) |
WO (2) | WO2002047667A2 (sl) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7214687B2 (en) | 1999-07-14 | 2007-05-08 | Almirall Ag | Quinuclidine derivatives and medicinal compositions containing the same |
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
US20030235538A1 (en) * | 2002-04-09 | 2003-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for the administration of an anticholinergic by inhalation |
PL373287A1 (en) * | 2002-05-07 | 2005-08-22 | Altana Pharma Ag | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders |
WO2003094968A2 (en) * | 2002-05-07 | 2003-11-20 | Altana Pharma Ag | Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases |
ATE405275T1 (de) * | 2002-12-12 | 2008-09-15 | Nycomed Gmbh | Kombinationsarzneimittel aus r,r-formoterol und ciclesonide |
US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
US20050026948A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a betamimetic |
CA2538419C (en) * | 2003-09-16 | 2012-07-03 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases |
SE0303570L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
PE20050941A1 (es) * | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
PL1713473T3 (pl) | 2004-02-06 | 2013-08-30 | Meda Pharma Gmbh & Co Kg | Kombinacja leków antycholinergicznych i glikokortykoidów do długotrwałego leczenia astmy i POChP |
EP1720577A2 (en) * | 2004-02-27 | 2006-11-15 | Altana Pharma AG | Ciclesonide and glycopyrronium combination |
WO2005102354A1 (en) * | 2004-04-20 | 2005-11-03 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
ES2257152B1 (es) | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
DE602005022499D1 (de) | 2004-05-31 | 2010-09-02 | Almirall Sa | Kombinationen mit Antimuskarin-Wirkstoffen und PDE4-Hemmern |
ES2298049B1 (es) | 2006-07-21 | 2009-10-20 | Laboratorios Almirall S.A. | Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano. |
EP2100599A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100598A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
WO2011093809A2 (en) * | 2010-01-28 | 2011-08-04 | Mahmut Bilgic | Dry powder pharmaceutical composition comprising tiotropium and ciclesonide |
TR200909792A2 (tr) | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
JP2014521714A (ja) | 2011-08-12 | 2014-08-28 | ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネコ科動物の心不全を治療および予防する方法において使用するための奇異性電流(If)阻害薬 |
WO2013095311A1 (en) * | 2011-11-25 | 2013-06-27 | Mahmut Bilgic | Inhalation device |
USD733288S1 (en) * | 2012-12-13 | 2015-06-30 | Interquim, S.A. | Inhalator |
LT2934544T (lt) * | 2012-12-21 | 2019-02-25 | Boehringer Ingelheim Vetmedica Gmbh | Farmacinė kompozicija, apimanti ciklezonidą |
NZ706573A (en) | 2012-12-21 | 2019-11-29 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for the treatment of airway disease in horses |
USD739522S1 (en) * | 2013-06-06 | 2015-09-22 | Lupin Atlantis Holdings Sa | Inhaler |
AU356657S (en) * | 2014-01-28 | 2014-07-29 | Lupin Ltd | Inhaler |
AU356658S (en) * | 2014-01-28 | 2014-07-29 | Lupin Ltd | Inhaler |
KR102618119B1 (ko) | 2014-06-18 | 2023-12-27 | 베링거잉겔하임베트메디카게엠베하 | 말의 기도 질환의 치료를 위한 무스카린 길항제 및 이의 병용물 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2540633A1 (de) * | 1975-09-12 | 1977-04-28 | Boehringer Sohn Ingelheim | Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung |
DE3211185A1 (de) * | 1982-03-26 | 1983-09-29 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung |
DE3215493A1 (de) * | 1982-04-26 | 1983-11-03 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung |
JPS625671A (ja) * | 1985-07-02 | 1987-01-12 | Sanyo Electric Co Ltd | 光起電力装置の製造方法 |
US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
DE4003270A1 (de) * | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgase und ihre verwendung in arzneimittelzubereitungen |
EP0504112A3 (en) * | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
DE4203306A1 (de) * | 1992-02-06 | 1993-08-12 | Ig Spruehtechnik Gmbh | Asthma oder pulmonal-aerosolzubereitungen mit lecithin |
US5770738A (en) * | 1992-03-05 | 1998-06-23 | Boehringer Ingelheim Kg | Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions |
DE19515625C2 (de) * | 1995-04-28 | 1998-02-19 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von enantiomerenreinen Tropasäureestern |
KR100392280B1 (ko) * | 1995-06-27 | 2003-11-19 | 베링거 인겔하임 카게 | 추진제비함유흡입성에어로졸을제조하기위한안정한추진제비함유약제학적용액 |
US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
NZ509418A (en) * | 1998-06-18 | 2003-06-30 | Boehringer Ingelheim Pharma | Pharmaceutical formulations for aerosols with two or more active substances |
DE19835346A1 (de) * | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
SE9803770D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Dry powder pharmaceutical formulation |
SE9804000D0 (sv) * | 1998-11-23 | 1998-11-23 | Astra Ab | New composition of matter |
DZ2947A1 (fr) * | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
US6506900B1 (en) * | 2001-01-31 | 2003-01-14 | Boehringer Ingelheim Pharma Ag | Process for preparing a scopine ester intermediate |
-
2000
- 2000-12-15 DE DE10062712A patent/DE10062712A1/de not_active Withdrawn
-
2001
- 2001-12-12 EP EP09165340A patent/EP2105143B8/de not_active Expired - Lifetime
- 2001-12-12 CA CA002431565A patent/CA2431565C/en not_active Expired - Fee Related
- 2001-12-12 SI SI200130953T patent/SI1349549T1/sl unknown
- 2001-12-12 EP EP01991827A patent/EP1349549B1/de not_active Expired - Lifetime
- 2001-12-12 DE DE50115147T patent/DE50115147D1/de not_active Expired - Lifetime
- 2001-12-12 MX MXPA03005340A patent/MXPA03005340A/es active IP Right Grant
- 2001-12-12 AU AU2002231691A patent/AU2002231691A1/en not_active Abandoned
- 2001-12-12 AT AT01991827T patent/ATE444067T1/de active
- 2001-12-12 WO PCT/EP2001/014567 patent/WO2002047667A2/de not_active Application Discontinuation
- 2001-12-12 DK DK01991827.5T patent/DK1349549T3/da active
- 2001-12-12 ES ES01991827T patent/ES2334104T3/es not_active Expired - Lifetime
- 2001-12-12 AU AU2002224926A patent/AU2002224926A1/en not_active Abandoned
- 2001-12-12 US US10/465,921 patent/US20040266869A1/en not_active Abandoned
- 2001-12-12 WO PCT/EP2001/014579 patent/WO2002047668A2/de active Application Filing
- 2001-12-12 DK DK09165340.2T patent/DK2105143T3/da active
- 2001-12-12 PT PT01991827T patent/PT1349549E/pt unknown
- 2001-12-12 PT PT91653402T patent/PT2105143E/pt unknown
- 2001-12-12 ES ES09165340T patent/ES2398009T3/es not_active Expired - Lifetime
- 2001-12-12 JP JP2002549242A patent/JP4537652B2/ja not_active Expired - Lifetime
-
2009
- 2009-12-21 CY CY20091101321T patent/CY1110582T1/el unknown
-
2013
- 2013-01-17 CY CY20131100051T patent/CY1113953T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2004515528A (ja) | 2004-05-27 |
CY1110582T1 (el) | 2015-04-29 |
MXPA03005340A (es) | 2004-04-02 |
EP2105143A1 (de) | 2009-09-30 |
ES2334104T3 (es) | 2010-03-05 |
AU2002224926A1 (en) | 2002-06-24 |
US20040266869A1 (en) | 2004-12-30 |
DK1349549T3 (da) | 2010-02-01 |
EP2105143B1 (de) | 2012-10-24 |
EP1349549A2 (de) | 2003-10-08 |
ATE444067T1 (de) | 2009-10-15 |
ES2398009T3 (es) | 2013-03-13 |
EP1349549B1 (de) | 2009-09-30 |
AU2002231691A1 (en) | 2002-06-24 |
CY1113953T1 (el) | 2016-07-27 |
DE50115147D1 (de) | 2009-11-12 |
PT2105143E (pt) | 2013-01-24 |
CA2431565C (en) | 2008-02-19 |
DE10062712A1 (de) | 2002-06-20 |
EP2105143B8 (de) | 2012-11-28 |
WO2002047667A3 (de) | 2002-10-24 |
WO2002047668A2 (de) | 2002-06-20 |
WO2002047668A3 (de) | 2002-08-29 |
JP4537652B2 (ja) | 2010-09-01 |
CA2431565A1 (en) | 2002-06-20 |
DK2105143T3 (da) | 2013-02-04 |
PT1349549E (pt) | 2009-11-04 |
WO2002047667A2 (de) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1349549E (pt) | Novas composições de produto farmacêutico à base de sais de tiotrópio e ciclesonida | |
PL350583A1 (en) | Combinations of formoterol and a tiotropium salt | |
HK1043048A1 (en) | Combinations of formoterol and mometasone furoate | |
SI1178832T1 (sl) | Novi sestavki zdravil na osnovi tiotropijevega bromida in salmeterola | |
SI1335728T1 (en) | Medicament compositions based on tiotropium salts and on salmeterol salts | |
WO2001026693A3 (en) | Manufacture of polyglutamate-therapeutic agent conjugates | |
AU2002227910A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
YU37301A (sh) | Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa | |
WO2003009838A1 (fr) | Utilisation de composes de stilbene dans la preparation de medicaments pour le traitement ou la prevention du diabete et des maladies associees au retrovirus | |
WO2002036135A3 (en) | Compositions for antitumour treatment containing ecteinascidin 743 | |
WO2002053090A3 (fr) | Association medicamenteuse d'une biguanine (metformine) et d'arginine | |
AU2003290015A1 (en) | Mastitis treatment | |
EP1570852A3 (de) | Xenon als Arzneimittel | |
AU2001285944A1 (en) | Fungicidal agent containing n-chlorotaurine and use thereof | |
WO2001041771A3 (de) | Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne | |
GB0128071D0 (en) | Medicament | |
IT1254632B (it) | Uso di acido iodesossicolico come promotore di assorbimento di farmaci | |
RU2000110690A (ru) | Способ антибиотикотерапии | |
IL161189A (en) | Use of factor xiii for preparation of a medicament for inhibiting the formation of seromas |